New York State Common Retirement Fund’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-223
| Closed | – | – | 3432 |
|
|
2022
Q2 | $0 | Sell |
223
-16,900
| -99% | – | ﹤0.01% | 3536 |
|
|
2022
Q1 | $149K | Sell |
17,123
-36,605
| -68% | -$319K | ﹤0.01% | 2919 |
|
|
2021
Q4 | $860K | Sell |
53,728
-17,492
| -25% | -$280K | ﹤0.01% | 2164 |
|
|
2021
Q3 | $1.31M | Buy |
71,220
+21,329
| +43% | +$393K | ﹤0.01% | 1994 |
|
|
2021
Q2 | $696K | Sell |
49,891
-8,638
| -15% | -$121K | ﹤0.01% | 2402 |
|
|
2021
Q1 | $862K | Hold |
58,529
| – | – | ﹤0.01% | 2185 |
|
|
2020
Q4 | $1.14M | Buy |
58,529
+13,200
| +29% | +$256K | ﹤0.01% | 1986 |
|
|
2020
Q3 | $506K | Buy |
45,329
+18,600
| +70% | +$208K | ﹤0.01% | 2206 |
|
|
2020
Q2 | $362K | Buy |
26,729
+8,300
| +45% | +$112K | ﹤0.01% | 2378 |
|
|
2020
Q1 | $149K | Buy |
18,429
+1,879
| +11% | +$15.2K | ﹤0.01% | 2602 |
|
|
2019
Q4 | $159K | Hold |
16,550
| – | – | ﹤0.01% | 2835 |
|
|
2019
Q3 | $175K | Buy |
16,550
+2,522
| +18% | +$26.7K | ﹤0.01% | 2834 |
|
|
2019
Q2 | $161K | Sell |
14,028
-622
| -4% | -$7.14K | ﹤0.01% | 2929 |
|
|
2019
Q1 | $188K | Sell |
14,650
-1,050
| -7% | -$13.5K | ﹤0.01% | 2745 |
|
|
2018
Q4 | $97K | Sell |
15,700
-450
| -3% | -$2.78K | ﹤0.01% | 2972 |
|
|
2018
Q3 | $170K | Hold |
16,150
| – | – | ﹤0.01% | 2900 |
|
|
2018
Q2 | $237K | Buy |
+16,150
| New | +$237K | ﹤0.01% | 2795 |
|